MyAverix Finance
US · Healthcare
Healios K.K (HLOSF)
Biotechnology
Healios K.K (HLOSF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for HLOSF
Healios K.K (HLOSF) — FAQ
What is HLOSF's P/E ratio?
The price-to-earnings (P/E) ratio for Healios K.K (HLOSF) is 18.00 (data as of 2026-03-24).
Does Healios K.K pay a dividend?
Dividend yield is not available in the current snapshot for Healios K.K (HLOSF). Check the MyAverix Finance app for the latest dividend data.
What sector is Healios K.K in?
Healios K.K (HLOSF) is classified in the Healthcare sector (Biotechnology industry).
What exchange is HLOSF listed on?
HLOSF is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.